Exane Derivatives’s US Bancorp USB Stock Holding History

Exane Derivatives’s Portfolio USB Stock Details USB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-766	Closed	-$40.7K	–	971
2022 Q1	$40.7K	Buy	+766	New	+$44K	0.01%	593
2021 Q4	–	Sell	-766	Closed	-$45.5K	–	1023
2021 Q3	$45.5K	Buy	+766	New	+$43.6K	0.01%	624

Other funds holding USB

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Exane Derivatives's USB Position: Q2 2022 in Review

Exane Derivatives sold out of US Bancorp (USB) in Q2 2022, closing a stake of 766 shares — an estimated $40.7K sold.

Exane Derivatives first reported a position in USB in Q3 2021 and held it in 2 quarters. The position peaked at $45.5K in Q3 2021. 1,686 funds tracked by Wall St. Rank hold USB as of Q2 2022.

Exane Derivatives reported no remaining US Bancorp position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 766 US Bancorp shares in Q2 2022, an estimated $40.7K.
Exane Derivatives first reported a position in US Bancorp in Q3 2021 and held it in 2 quarters.
Exane Derivatives's US Bancorp position peaked at $45.5K in Q3 2021.
1,686 funds tracked by Wall St. Rank held US Bancorp as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.